Index -
P/E -
EPS (ttm) -0.01
Insider Own 16.00%
Shs Outstand 34.26M
Perf Week 1.71%
Market Cap 28.12M
Forward P/E -
EPS next Y -0.14
Insider Trans 1.17%
Shs Float 28.71M
Perf Month -18.53%
Enterprise Value 23.66M
PEG -
EPS next Q -0.05
Inst Own 20.38%
Short Float 0.59%
Perf Quarter -26.54%
Income -0.55M
P/S 0.29
EPS this Y -550.00%
Inst Trans -24.25%
Short Ratio 0.78
Perf Half Y -59.86%
Sales 97.73M
P/B 0.89
EPS next Y 28.21%
ROA -1.06%
Short Interest 0.17M
Perf YTD -59.67%
Book/sh 0.92
P/C 1.62
EPS next 5Y -
ROE -2.12%
52W High 5.15 -84.02%
Perf Year -50.73%
Cash/sh 0.51
P/FCF 13.02
EPS past 3/5Y 81.27% 66.71%
ROIC -1.31%
52W Low 0.78 5.47%
Perf 3Y -39.50%
Dividend Est. -
EV/EBITDA 8.60
Sales past 3/5Y 17.90% 10.61%
Gross Margin 17.87%
Volatility 5.23% 5.35%
Perf 5Y -95.82%
Dividend TTM -
EV/Sales 0.24
EPS Y/Y TTM 96.46%
Oper. Margin 0.59%
ATR (14) 0.05
Perf 10Y -99.50%
Dividend Ex-Date -
Quick Ratio 2.50
Sales Y/Y TTM 12.82%
Profit Margin -0.57%
RSI (14) 35.58
Recom 1.00
Dividend Gr. 3/5Y - -
Current Ratio 2.95
EPS Q/Q 24.75%
SMA20 -9.28%
Beta 1.62
Target Price 4.00
Payout -
Debt/Eq 0.41
Sales Q/Q -16.59%
SMA50 -17.78%
Rel Volume 0.74
Prev Close 0.82
Employees 244
LT Debt/Eq 0.34
Earnings May 12 BMO
SMA200 -59.31%
Avg Volume 217.35K
Price 0.82
IPO Jan 27, 1998
Option/Short Yes / Yes
EPS/Sales Surpr. 20.00% 8.33%
Trades
Volume 160,882
Change 0.56%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-14-24 Initiated
Rodman & Renshaw
Buy
$5
Jun-24-19 Initiated
Piper Jaffray
Overweight
$10
May-13-19 Initiated
H.C. Wainwright
Buy
$11
Nov-08-16 Downgrade
BofA/Merrill
Neutral → Underperform
Mar-01-16 Downgrade
Stifel
Buy → Hold
Aug-13-15 Initiated
Morgan Stanley
Underweight
$7
Jan-27-15 Reiterated
Oppenheimer
Outperform
$24 → $26
Jan-07-15 Initiated
Oppenheimer
Outperform
$24
Aug-14-14 Initiated
FBR Capital
Underperform
$6
Dec-19-13 Initiated
Chardan Capital Markets
Buy
$22
Nov-06-13 Reiterated
Summer Street Research
Buy
Sep-05-13 Reiterated
Summer Street Research
Buy
$20 → $25
Aug-02-13 Reiterated
Summer Street Research
Buy
$20
Apr-11-12 Initiated
Summer Street Research
Buy
$20
Mar-12-12 Initiated
Stifel Nicolaus
Buy
$15
Jan-03-12 Initiated
Canaccord Genuity
Buy
$14
Dec-10-09 Initiated
JMP Securities
Mkt Outperform
$11
Oct-12-09 Initiated
Wedbush Morgan
Outperform
$12
Show Previous Ratings
May-13-25 03:03AM
May-12-25 10:07PM
(Thomson Reuters StreetEvents) -7.14%
07:15AM
06:11AM
(Associated Press Finance)
06:00AM
09:20AM
Loading…
May-08-25 09:20AM
Apr-14-25 06:00AM
Mar-21-25 07:08AM
03:02AM
Mar-20-25 11:44PM
(Thomson Reuters StreetEvents) -20.45%
09:37AM
09:36AM
07:10AM
06:18AM
(Associated Press Finance)
06:00AM
06:00PM
Loading…
Mar-19-25 06:00PM
Mar-11-25 06:00AM
Feb-27-25 06:00AM
Feb-20-25 06:00AM
Feb-04-25 06:00AM
Dec-17-24 07:51AM
06:00AM
Dec-13-24 03:48PM
12:11PM
Dec-12-24 06:00AM
Dec-05-24 06:00AM
Nov-19-24 06:00AM
Nov-13-24 02:06AM
Nov-12-24 10:01PM
(Thomson Reuters StreetEvents) -39.14%
07:10AM
06:12AM
Loading…
06:12AM
(Associated Press Finance)
06:00AM
Nov-11-24 07:21AM
Nov-08-24 07:06AM
06:00AM
Oct-17-24 12:00PM
Oct-14-24 06:00AM
Oct-09-24 05:33PM
Sep-20-24 09:15AM
Sep-18-24 06:00AM
Sep-09-24 12:00PM
08:50AM
06:00AM
Sep-04-24 09:15AM
Sep-03-24 06:00AM
Aug-19-24 09:15AM
Aug-15-24 08:50AM
Aug-08-24 07:15AM
06:13AM
(Associated Press Finance)
06:00AM
Aug-07-24 06:00AM
Jul-15-24 06:45AM
Jul-11-24 06:00AM
May-30-24 06:00AM
May-15-24 08:19AM
03:01AM
12:37AM
(Thomson Reuters StreetEvents)
May-14-24 10:54AM
07:15AM
06:11AM
(Associated Press Finance)
06:00AM
Apr-17-24 06:00AM
Apr-16-24 06:00AM
Apr-04-24 06:00AM
Mar-26-24 06:15PM
Mar-25-24 06:00AM
Mar-22-24 09:52AM
Mar-21-24 09:39PM
(Thomson Reuters StreetEvents) -7.88%
10:53AM
07:10AM
06:18AM
(Associated Press Finance)
06:00AM
Mar-11-24 06:15PM
Mar-05-24 06:00PM
Feb-27-24 06:00PM
Feb-20-24 06:00PM
Feb-14-24 06:00PM
Feb-08-24 06:00AM
Jan-08-24 07:30AM
Nov-15-23 01:29PM
Nov-14-23 10:36PM
(Thomson Reuters StreetEvents)
07:15AM
06:06AM
(Associated Press Finance)
06:00AM
Nov-07-23 06:00PM
Oct-26-23 06:00PM
Oct-20-23 06:15PM
Oct-18-23 06:00AM
Oct-17-23 06:00AM
Oct-16-23 06:00AM
Oct-13-23 06:15PM
Oct-03-23 06:15PM
06:00AM
Sep-28-23 06:00AM
Sep-27-23 06:15PM
Sep-21-23 06:15PM
06:30AM
Sep-18-23 11:37AM
Sep-07-23 06:00AM
Aug-15-23 12:29PM
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini on October 25, 1996 and is headquartered in Wixom, MI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Chole Timothy SVP and CCO Jul 01 '25 Sale 0.82 2,868 2,352 128,167 Jul 02 05:22 PM Neri Jesse SVP and CFO Jul 01 '25 Sale 0.82 886 727 126,614 Jul 02 05:20 PM Strobeck Mark President and CEO Jul 01 '25 Sale 0.82 6,926 5,679 337,752 Jul 02 05:17 PM Strobeck Mark Officer Jul 01 '25 Proposed Sale 0.80 6,926 5,536 Jul 01 01:12 PM Chole Timothy Officer Jul 01 '25 Proposed Sale 0.79 2,868 2,271 Jul 01 01:07 PM Neri Jesse Officer Jul 01 '25 Proposed Sale 0.79 886 697 Jul 01 01:03 PM Irrevocable Larson Family Inve 10% Owner Apr 10 '25 Buy 1.07 57,000 61,036 3,527,000 Apr 15 02:02 PM Irrevocable Larson Family Inve 10% Owner Apr 11 '25 Buy 1.08 30,500 32,982 3,557,500 Apr 15 02:02 PM Strobeck Mark President and CEO Apr 01 '25 Sale 1.08 6,926 7,480 124,678 Apr 02 06:06 PM Neri Jesse SVP, FINANCE AND CFO Apr 01 '25 Sale 1.10 886 975 30,000 Apr 02 06:05 PM Chole Timothy SVP, Chief Commercial Officer Apr 01 '25 Sale 1.08 2,868 3,097 46,035 Apr 02 06:03 PM Strobeck Mark Officer Apr 01 '25 Proposed Sale 1.05 6,926 7,263 Apr 01 01:49 PM Chole Timothy Officer Apr 01 '25 Proposed Sale 1.05 2,868 3,000 Apr 01 01:43 PM Neri Jesse Officer Apr 01 '25 Proposed Sale 1.06 886 939 Apr 01 01:18 PM Chole Timothy SVP, Chief Commercial Officer Jan 02 '25 Sale 2.05 1,001 2,052 54,170 Jan 06 04:44 PM Strobeck Mark President and CEO Jan 02 '25 Sale 2.06 2,163 4,445 145,038 Jan 06 04:43 PM Strobeck Mark Officer Jan 02 '25 Proposed Sale 2.06 2,163 4,445 Jan 02 03:18 PM Chole Timothy Officer Jan 02 '25 Proposed Sale 2.01 1,001 2,015 Jan 02 12:40 PM RAVICH MARK H Director Nov 15 '24 Sale 2.32 19,991 46,379 0 Nov 19 04:21 PM RAVICH MARK H Director Nov 15 '24 Sale 2.40 10,000 24,000 121,429 Nov 19 04:21 PM Chole Timothy SVP, Chief Commercial Officer Oct 01 '24 Sale 3.69 1,001 3,689 55,171 Oct 02 09:55 PM Strobeck Mark President and CEO Oct 01 '24 Sale 3.69 2,163 7,971 147,201 Oct 02 09:54 PM Strobeck Mark Officer Oct 01 '24 Proposed Sale 3.65 2,163 7,900 Oct 01 02:05 PM Chole Timothy Officer Oct 01 '24 Proposed Sale 3.60 1,001 3,600 Oct 01 01:36 PM